• Users Online: 8529
  • Print this page
  • Email this page

Year : 2007  |  Volume : 51  |  Issue : 5  |  Page : 365 Table of Contents     

Monitoring Devices for Measuring the Depth of Anaesthesia - An Overview

1 MD, Associate Professor, Department of Anaesthesiology, Sree Chitra Tirunal Institute for Medical Sciences & Technology, Trivandrum - 695011, Kerala, India
2 MD, Additional Professor, Department of Anaesthesiology, Sree Chitra Tirunal Institute for Medical Sciences & Technology, Trivandrum - 695011, Kerala, India

Date of Acceptance20-Aug-2007
Date of Web Publication20-Mar-2010

Correspondence Address:
Prabhat Kumar Sinha
H. No. KP IX/561, Chettikunnu, Podujanam Lane, Kumarpuram, Trivandrum -695011, Kerala
Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

Achieving adequate depth of anaesthesia during surgical procedures is desirable. Therefore, assessment and monitoring/ measurement of the depth of anaesthesia are fundamental to anaesthetic practice. The purpose of this review is to identify the risk factors that may be associated with intraoperative awareness, provide decision tools that may enable the clinician to reduce the frequency of unintended intraoperative awareness, stimulate the pursuit and evaluation of strategies that may prevent or reduce the frequency of intraoperative awareness, different types of tools developed to date to monitor the depth of anaesthesia, provide guidance for the intraoperative use of different monitoring tools as they relate to intraoperative awareness and how to approach a patient when awareness is reported by the patient along with current guidelines in the use of current available monitors.

Keywords: Anaesthesia; Monitoring; Awareness

How to cite this article:
Sinha PK, Koshy T. Monitoring Devices for Measuring the Depth of Anaesthesia - An Overview. Indian J Anaesth 2007;51:365

How to cite this URL:
Sinha PK, Koshy T. Monitoring Devices for Measuring the Depth of Anaesthesia - An Overview. Indian J Anaesth [serial online] 2007 [cited 2021 Jun 24];51:365. Available from: https://www.ijaweb.org/text.asp?2007/51/5/365/61166

   Introduction Top

Achieving adequate depth of anaesthesia during surgical procedures is desirable. While deep level of anaesthesia, resulting in cardiovascular depression (easy to detect) and prolonged awakening times (a rather harm­less complication) is of minor clinical interest, the oppo­site - light anaesthesia - is more difficult to detect and frightening from the patients point of view. Therefore, assessment of the depth of anaesthesia is fundamental to anaesthetic practice. Prior to the use of muscle relax­ants, maintaining the appropriate depth of anaesthesia was a balance between abolishing movement to pain whilst maintaining adequate respiration. With the absence of movement on incision it was safe to assume that the patient was not aware, however with the use of muscle relaxants it became necessary to be certain that the ad­ministered concentration of anaesthetic agent was ad­equate to prevent awareness. With the emergence of new anaesthetic techniques such as intravenous anaes­thesia, the use of potent opiate analgesics, newer vola­tile agents and more complicated regional nerve blocks, a means of measuring depth of anaesthesia is important. However, in 1937, Dr Arthur E. Guedel refined this sys­tem and developed a chart classification of ether anaes­thesia based on lacrimation, pupil size and position, res­piratory pattern and peripheral movement. What began as the continuous clinical monitoring of patients' physi­ological parameters evolved to include the measurement of real-time airway gas volatile agent concentration and more recently the analysis of neurophysiological param­eters.

The purpose of this review is to identify risk fac­tors that may be associated with intraoperative aware­ness, provide decision tools that may enable the clinician to reduce the frequency of unintended intraoperative awareness, stimulate the pursuit and evaluation of strategies that may prevent or reduce the frequency of intra­operative awareness, different types of tools developed to date to monitor the depth of anaesthesia and provide guidance for the intraoperative use of different monitor­ing tools as they relate to intraoperative awareness and how to approach a patient when awareness is reported by the patient along with current guidelines in the use of current available monitors.

Intraoperative awareness under general anaesthe­sia is a rare occurrence with a reported incidence of 1 to a few in 1000 general anaesthesia cases [1],[2] with three major risk factors: trauma, caesarean section and car­diovascular surgery. The hereby increased incidences of intraoperative awareness are easy to re-enact. Un­der these circumstances light anaesthesia is intention­ally put at risk in order to avoid severe cardiovascular depression or fetal impairment respectively. However, there is a risk for the anaesthesiologist too, since some of these patients take legal action. A closed claims analy­sis of more than 4100 anaesthesia related claims in the U.S.A. has shown that despite all advantages in modern anaesthesia, there is an increasing incidence of claims concerning intraoperative awareness, 1% in the 1980s, 2% in the 1990s and 3% in the last decade [3] . Surpris­ingly, risk factors for claims were totally different from the above cited "classical" risk factors: age at around 40 years, ASA physical status I or II, routine surgery and female gender. Significant psychological sequelae (e.g., post-traumatic stress disorder) may occur after an epi­sode of intraoperative awareness, and affected patients may remain severely disabled for extended periods of time [4] . However, in some circumstances, intraoperative awareness may be unavoidable to achieve other criti­cally important anaesthetic goals.

Following terminology would be helpful in better understanding of the article. These are

1. Depth of anaesthesia. Depth of anaesthesia or depth of hypnosis refers to a continuum of progres­sive central nervous system depression and decreased responsiveness to stimulation.

2. Recall. It is the patient's ability to retrieve stored memories. Recall is assessed by a patient's report of previous events, in particular, events that occurred dur­ing general anaesthesia. Recall can be either explicit or implicit. Explicit memory: It refers to intentional or con­scious recollection of prior experiences as assessed by the patient's ability to recall specific events that took place during general anaesthesia by certain tests or re­call or recognition, so called direct memory test. Implicit memory (perception without conscious recall): The pa­tient denies recall, but may remember "something" un­der hypnosis. Psychologists are sceptical about the ex­istence of this phenomenon.

3. Amnesia. Amnesia is the absence of recall. Many anaesthetic drugs produce amnesia at concentra­tions well below those necessary for suppression of con­sciousness. Anterograde amnesia is intended when a drug with amnestic properties is administered before in­duction of anaesthesia. Retrograde amnesia is intended when a drug such as a benzodiazepine is administered after an event that may have caused or been associated with intraoperative consciousness in the hope that it will suppress memory formation and "rescue" from recall.

4. Burst suppression. Burst suppression (BS) pattern is a characteristic behaviour of the EEG which can be recognized during deep anaesthesia. It consists of periods of high amplitude (bursts) followed by periods of near "silence" or very low amplitude (suppression). The duration of both periods is in the range of seconds. BS can occur as a consequence of the administration of high concentrations of anaesthetics and is also a char­acteristic of a state of low brain activity associated with hypothermia or ischaemia. Caution should be exercised if BS arises when the anaesthetic concentration has not been changed or the temperature lowered. In this case BS can be an indicator of cerebral ischaemia. BS ratio (%) is the ratio of the amount of flat EEG to raw EEGX100.

5. Signal Quality Index (SQI%). SQI% mea­sures the quality of the acquired EEG signal. The calcu­lation is based on a number of artifacts during the last minute. The electrode-to-skin impedance is included in the SQI% calculation. Higher electrode-to-skin imped­ances reduce the SQI%. If the impedance of the sen­sors exceeds 1kΩ,, the SQI will fall gradually. Poor im­pedance conditions may cause the SQI to fall to 50%. Impedances at 1kΩ,) will result in a SQI% of 100. This quantity is displayed numerically as a percentage (0-100%, 100% equals best signal quality).

6. EMG%. Amount of electromyographic (EMG) activity occurring over a fixed period of time.

7. Spectral edge frequency (SEF). It indicates the spectral frequency below which containsthe power in the EEG .

8. Total power (TP). It describes the overall per­centage of EEG power over the entire EEG frequency spectrum.

Classification of awareness:

It is classified by Griffith and Jones [5] as follows:

  1. Conscious awareness with complaint of pain per­caption
  2. Conscious awareness with explicit recall but with­out pain
  3. Conscious awareness or "wakefulness" (ability to respond to simple verbal commands)
  4. Without explicit recall and pain but possible implicit memory
  5. Subconscious awareness without explicit recall but evidence of implicit memory of intraoperative events
  6. No awareness

Causes of awareness:

In practice, about 95% of cases of awareness are due to human error or faulty anaesthetic technique or apparatus failure [6] such as failure to turn on the anaes­thetic or monitor the patient. In only about 2.5% of cases can no cause be found. It is also interesting to note that only about 2.5% of claims of awareness are spurious [6] . The curve relating the minimum alveolar concentration of inhaled anaesthetic to produce loss of consciousness (MAC awake ) to the number of people with that MAC awake is normally distributed, so some patients do require sig­nificantly higher doses of anaesthetic [7] . This variability may explain awareness in those cases where no other cause is apparent. Claims for damages from awareness have thus been successfully defended when careful an­aesthetic records were kept and apparatus appropriately checked. More commonly, awareness may result when difficulty is encountered with intubation. Generally, anaesthesia is induced with an intravenous agent, followed by administration of a muscle relaxant and intubation of the trachea after which the patient's lungs are ventilated with oxygen, nitrous oxide and inhalational anaesthetic. If the process of intubation takes longer than anticipated and a short-acting intravenous agent has been used, a period of time may occur between intravenous agents declining, before starting the inhalational agent, which could lead to awareness.

Anaesthesiologists now use a variety of different indicators to measure depth of anaesthesia, many of which rely upon monitoring more accurately the changes in nor­mal physiological variables such as heart rate and blood pressure. Although variations in these parameters can be associated with variations in the level of anaesthesia, many studies have demonstrated that they are not completely reliable. Accurate monitoring of the level of conscious­ness and the potential awareness of an anaesthetized pa­tient require different techniques. Volatile agent monitor­ing, linked to the concept of minimum alveolar concentra­tion (MAC), is employed currently as a reliable measure­ment for routine use in this area, and yet the incidence of intraoperative awareness has not changed in recent years. Indeed, a major study demonstrated the frequency of in­traoperative awareness was the same whether or not end­ tidal agent monitoring was used during the general anaes­thetic. Clearly, agent monitoring is of no value when total intravenous anaesthesia is used.

   Methods of monitoring depth of anaesthesia Top

There are various ways to measure or monitor depth of anaesthesia based on clinical/conventional moni­toring and/or brain electrical activity monitoring [Table 1]

A. Clinical techniques and conventional monitor­ing:

Among the clinical techniques used to assess in­traoperative consciousness are checking for movement, response to commands, eyelash reflex, pupillary re­sponses or diameters, perspiration, and tearing. Conven­tional monitoring systems include ASA standard moni­toring as well as end-tidal anaesthetic analyzer. No clini­cal trials or other comparative studies were found that examine the effect of clinical techniques or conventional monitoring on the incidence of intraoperative awareness.

I. Clinical signs: The most commonly used scor­ing system incorporates the PRST or Evan's score [8] . This assesses autonomic activity related to P (systolic blood P ressure), R (heart R ate), S ( S weating) and T ( T ears). This system has the advantages of being simple and not requiring any specialized equipment, but the parameters are not specific for the effects of anaesthesia and the values can vary widely among individuals. The scores range from 0 to 8 but the midpoint is seldom exceeded, reflecting the inadequacy of this scoring system. Mea­surement of heart rate and blood pressure while regu­larly assessing pupil size, and the presence of sweating and lacrimation, provide useful information regarding the adequacy of analgesia and depth of anaesthesia. Tachy­cardia secondary to anticholinergic drugs such as atropine make the heart rate uninterpretable, and beta-adrener­gic blocking drugs, opiates and regional anaesthetic tech­niques will obtund the sympathetic nervous system re­sponse to pain. It has been agreed upon by ASA task force members on practice advisory for intraoperative awareness and brain function monitoring [9] that clinical techniques (e.g., checking for purposeful or reflex move­ment) are valuable and should be used to assess intraop­erative consciousness. In addition, conventional moni­toring systems (e.g., electrocardiogram, blood pressure, HR, end-tidal anaesthetic analyzer, capnography) are valuable and should be used to help assess intraopera­tive consciousness.

II. Skin conductance: Measurement of skin con­ductance is, in effect, a quantification of the clinical sign of sweat production. Goddard GF [10] found a reasonable correlation with anaesthetic depth in 67 patients. Skin conductance was initially low and increased as anaes­thetic depth was increased, reducing again with surgical incision. Other factors affecting sweating (e.g. atropine, autonomic neuropathy) can reduce the accuracy of this monitoring.

III. Isolated forearm technique: The isolated forearm technique is a method of detecting awareness during clinical practice and experimentally. A tourniquet is applied to the patient's upper arm, inflated above sys­tolic blood pressure before the administration of muscle relaxants. Movement of the arm either spontaneously or to command indicated wakefulness, although not neces­sarily explicit awareness. It has been used previously as a means of detecting awareness during caesarean section under general anaesthesia and during clinical trials assessing rates of awareness. Some would argue that response to command during surgery is a late sign when attempting to prevent awareness however not all pa­tients responding have any recall. One limitation of this technique is the limited time available before patients are unable to move their arm due to tourniquet induced ischaemia.

IV. Spontaneous surface electromyogram (SEMG): In patients who are not completely paralyzed, spontaneous surface electromyogram (SEMG) can be recorded from various muscle groups, especially facial, abdominal and neck muscles. Frontalis muscle is inner­vated by a branch of the facial nerve and is less af­fected by the neuromuscular blockade. A stick on electrode positioned over the frontalis muscle can record the frontalis electromyogram (FEMG). The level of FEMG has been observed to fall during anaesthesia and to rise to pre-anaesthetic levels just before awakening [11] .

V. Lower oesophageal contractility (LOC): The non-striated muscles in the lower half of oesophagus retain their potential activity even after full skeletal muscle paralysis by neuromuscular blocking agents. Measurements of LOC therefore, provide two prime derivatives.

(i) Spontaneous lower oesophageal contrac­tility (SLOC). It arises spontaneously and can be de­tected by a pressure transducer. It can be induced by emotion and stress in the awake individual. It is believed that SLOC are under the control of a central oesoph­ageal motility centre, the activity of which is influenced by higher centres.

(ii) Provoked lower oesophageal contractility (PLOC). These result from sudden distension of the oesophagus, as if due to the arrival of a food bolus. PLOC are induced by the rapid inflation of a balloon catheter in the lower oesophagus. This causes smooth muscle contraction and is detected by a more distally placed pres­sure transducer. The dose-response curve for PLOC is shallower than that of SLOC. Evans and colleagues [12] were the first to propose that depth of anaesthesia might be measured by the degree of spontaneous contractions of lower oesophagus. Spontaneous and provoked lower oesophageal contractions both reduce in latency and amplitude during general anaesthesia. These are mea­sured using a balloon in the oesophagus; however, pub-lashed evidence of its use as a depth of anaesthesia moni­tor is limited. One way of improving the available infor­mation is by combining the measurement of SLOC frequency with PLOC amplitude, leading to the deriva­tion of the oesophageal contractility index (OCI):OCI = 70 x (SLOC rate + PLOC amplitude). The OCI is easy to interpret and can be used in the presence of muscle relaxants; however, consensus opinion is against this method being a reliable measure of anaesthetic depth [13] .

VI. Heart rate variability: Recent research us­ing animal models have shown that the anaesthetic agents either directly or indirectly first acts on the brain stem and then probably inhibit the cerebral cortex via ascend­ing efferent projections from the midbrain. Therefore, objective measurement of brain stem-mediated auto­nomic tone that is not affected by any factor other than anaesthetic depth may be a good indicator of depth of anaesthesia. The special analysis of HRV revealed 3 components: 1) Low frequency fluctuations; believed to be circadian. 2) Medium frequency fluctuations; attrib­uted to baroreceptor reflex. 3) High frequency fluctuations HRV coincides with the frequency of ventilation, in which heart rate increases during inspiration and de­creases during expiration, through a predominantly parasympathetic reflex connecting stretch receptors in the lungs and aorta to vagal motor neurons innervating the heart. This is called as respiratory sinus arrhythmia (RSA). It is typically characterized by greater than 10% variation in the ECG P-wave interval over 5 minutes. RSA is easily visible on an ECG monitor that is time locked to an ECG R-wavepeak, but is difficult to distin­guish with a rolling display. Various studies [14],[15] have shown that the level of RSA reflects the level of anaes­thetic depth. In addition, surgical stimulation during light anaesthesia elicits a greater increase on RSA than seen during lightening anaesthesia alone. Some monitors use HRV at respiratory frequency or respiratory sinus ar­rhythmia (RSA) as a method of assessing anaesthetic depth. This is useful, but depends on an intact autonomic nervous system and healthy myocardial conducting sys­tem. Beta-blockers, conduction abnormalities, autonomic neuropathy and sepsis all cause problems. The 'Fathom' (Amtec Medical Limited) is based on the use of HRV, and does not use cortical activity directly but depends on the influence of respiration on the brain stem and the resulting change in heart rate. At this stage, experience with the Fathom monitor is very limited.

B. Brain electrical activity monitoring:

Most of the devices designed to monitor brain elec­trical activity for the purpose of assessing anaesthetic effect record EEG activity from electrodes placed on the forehead. Systems can be subdivided into those that process spontaneous EEG and EMG activity and those that acquire evoked responses to auditory stimuli i.e. auditory evoked potential (AEPs). After amplification and conversion of the analog EEG signal to the digital domain, various signal processing algorithms are applied to the frequency, amplitude, latency, and/or phase rela­tionship data derived from the raw EEG or AEP to gen­erate a single number, often referred to as an "index," typically scaled between 0 and 100. This index repre­sents the progression of clinical states of consciousness ("awake," "sedated," "light anaesthesia," "deep anaes­thesia"), with a value of 100 being associated with the awake state and values of 0 occurring with an isoelec­tric EEG (or absent middle latency AEP). Artifact rec­ognition algorithms intended to avoid contaminated and therefore spurious "index" values are an important com­ponent of the software in most monitors. Although EMG activity from scalp muscles can be considered an arti­fact from the viewpoint of pure EEG analysis, it may be an important source of clinically relevant information. Sudden appearance of frontal (forehead) EMG activity suggests somatic response to noxious stimulation result­ing from inadequate analgesia and may give warning of impending arousal. For this reason, some monitors sepa­rately provide information on the level of EMG activity.

1. Spontaneous EEG activity monitors:

(i) EEG:
An EEG can be obtained using the standard 19-electrode method; however, this is time-consum­ing and impractical and requires expert interpretation. In its unprocessed form, it is not a practical tool for moni­toring depth of anaesthesia. Increasingly sophisticated, automated analysis of various EEG components has gen­erated several potential quantitative descriptors of an­aesthetic depth. There are two generic problems with processed EEG technologies: 1. Dissimilar anaesthetic agents generate different EEG patterns or signatures and 2. Various pathophysiological events also affect the EEG (e.g. hypotension, hypoxia, hypercarbia). Such events may modify both the patient's level of consciousness and the expected EEG signature that any given anaesthetic agent generates, thus confounding interpretation.

(ii) Compressed spectral analysis: The com­pressed spectral array (CSA) is obtained by superim­posing linear plots of successive epochs of time on each other, generating a three-dimensional 'hill and valley' dis­play of the power amplitude vertically (y-axis), frequency horizontally (x-axis) and time (z-axis). However, as suc­cessive epochs are added to the display, information can become hidden behind 'hills' of increased power at par­ticular frequencies. In order to reduce this problem, some displays arbitrarily truncate the peaks of high-amplitude activity, consequently affecting the legibility of the trace. This reflects cerebral electrical activity rather than pe­ripheral muscular or autonomic changes. Anaesthesia causes a reduction in high-frequency and an increase in low-frequency amplitudes, which is easier to interpret than raw EEG . However, there remain the problems of great patient- and agent variability and the confounding effects of other pathophysiological processes such as hypoxia, hypotension and hypercarbia. It is not a reliable monitor of the depth of anaesthesia, but can provide a trend for use in conjunction with clinical observations.

(iii) EEG with compressed spectral analysis: Philips EEG measurement module produces real-time waveforms from two channels. Software algorithms fil­ter typical artifacts from eye movement and pulse, among others. The EEG module is designed for continuous, real­time monitoring of adult, paediatric and neonatal patients in anaesthesia and intermediate/critical care environ­ments. The module provides the following measurements: Two channels of raw real-time EEG waves, CSA for each channel of EEG, Total power (TP), % TP in each frequency band (δ,γ,α,β), Spectral edge frequency, Mean dominant frequency, Peak power frequency, and Continuous impedance for each electrode.

(iv) Cerebral function monitor (CFM): This device is modified from the conventional EEG for use during anaesthesia. It uses a single biparietal or bitem­poral lead (three wires) to obtain an EEG signal. This signal is filtered, semi-logarithmically compressed, and rectified. The output is displayed at a very slow chart speed, 1 mm/minute, giving a trace as seen in the accompanying examples. As a result of this processing, the output is no longer a regular EEG signal but is, rather, a representation of the overall electrocortical background activity of the brain. A high reading on the chart indi­cates a high level of activity. A low value indicates low activity. It has been used in cardiac, neuro- and vascular surgery, where trends in activity may reflect changes in cerebral perfusion. The CFM has been used to monitor anaesthetic depth, but interest has fallen for several rea­sons. It can be unreliable, especially when using inhala­tional anaesthetic agents and the response to increasing depth of anaesthesia is biphasic, complicating dose-re­sponse interpretation. Values similar to those seen in awake patients may be seen in anaesthetized individu­als, while recovery from anaesthesia does not necessar­ily occur near baseline values. Additionally, burst sup­pression at deep levels of anaesthesia is characterized on the EEG by periods of normal or high-voltage activity alternating with periods of low or no activity. As the CFM provides a smoothed running average of the EEG volt­age, early burst suppression artificially elevates the read­ing, producing an apparent, paradoxical rise in 'cerebral function'.

(v) Cerebral function analysis monitor (CFAM): This device produces a continuous display of an analyzed EEG signal from two symmetrical pairs of scalp electrodes. The top trace displayed shows the mean amplitude of the signal plotted in time (90% confidence interval), while the bottom trace shows the power am­plitude in the frequency band. Thus, at any instant the CFAM display shows the overall mean amplitude and relative power in each frequency band (α,β,γ,δ). It is said to be more useful than the CFM, but suffers from the same drawbacks.

(vi) Bispectral Index : BIS is a proprietary algo­rithm (Aspect Medical Systems, Natick, MA) [Figure 1] and [Figure 2] that converts a single channel of frontal EEG into an index of hypnotic level (BIS). To compute the BIS, sev­eral variables derived from the EEG time domain (burst­suppression analysis), frequency domain (power spec­trum, bispectrum:interfrequency phase relationships) are combined into a single index of hypnotic level. BIS is developed by recording EEG data from healthy adults, who underwent repeated transitions between conscious­ness and unconsciousness, using several different an­aesthetic regimens. The raw EEG data were time stamped at various clinical end-points. A multivariate lo­gistic regression was used in offline analysis and identi­fied those features of the EEG recordings that best cor­related with clinical depth of sedation/anaesthesia, and these were then fitted to a model. The resulting algo­rithm generates the BIS. The weight factors for the vari­ous components in the multivariate model that generates the BIS were empirically derived from a prospectively collected database of more than 1,500 anaesthetics. The BIS model accounts for the nonlinear stages of EEG activity by allowing different parameters to dominate the resulting BIS as the EEG changes its character with in­creasing plasma concentrations of various anaesthetics, resulting in a linear decrease in BIS. The BIS monitor generates a dimensionless number on a continuous scale of 0-100, with 100 representing normal cortical electri­cal activity and 0 indicating cortical electrical silence [Figure 1]. As with any EEG signal, BIS is subject to interfer­ence and artifact, particularly from EMG activity, which can artificially elevate the recorded BIS. The display also shows a signal quality index and an indicator of EMG interference. Because there is no 'gold standard' moni­tor against which to compare BIS, studies have used predictive probability outcome measures - that is, the likelihood of various clinically relevant end-points occur­ring (loss of consciousness, recovery of consciousness, postoperative recall, suppression of learning) at differ­ent BIS values. From these various studies, broad guide­lines have emerged to aid the interpretation of BIS val­ues. The probability of postoperative recall is very low when BIS is kept <60intraoperatively. Results from vol­unteer studies demonstrate that BIS correlates well with clinical assessments of sedation induced by sedative­ hypnotic drugs [16] . BIS is also regarded as valuable moni­tor of the level of sedation and loss of consciousness for propofol, midazolam, and isoflurane [17] .

Several randomized controlled trials (RCTs) have compared outcomes with BIS-guided anaesthetic admin­istration versus standard clinical practice without BIS. In one RCT that enrolled 2,500 patients at high risk of intraoperative awareness, explicit recall occurred in 0.17% of patients when BIS monitors were used and in 0.91%of patients treated by routine clinical practice (P< 0.02) [18] . A small (n = 30), single-blinded RCT (i.e., the anaesthesiologists were blinded to the recorded BIS val­ues) compared BIS monitoring with clinical signs during cardiac surgery and reported one episode of recall in the clinical signs group compared with no episodes in the BIS monitored group (P > 0.50) [19] . In other RCTs, times to awakening, first response, or eye opening and con­sumption of anaesthetic drugs were reduced with the use of BIS [3] . Another prospective nonrandomized cohort study (n =19,575) designed to establish the incidence of awareness with recall during routine general anaesthe­sia and to determine BIS values associated with intraop­erative awareness events reported no statistically sig­nificant difference when BIS was used (0.18% of pa­tients) compared with when BIS was not used (0.10% of patients) [2] . Other nonrandomized comparative studies reported higher index values on arrival in the post-ana­esthesia care unit, shorter recovery times, and lower anaesthetic use among patients monitored with BIS com­pared with patients not monitored with BIS [20] . Wide ranges of mean BIS values have been reported during various intraoperative times [9] . Several case reports indicate that intraoperative events unrelated to titration of anaesthetic agents can produce rapid changes in BIS values (e.g., cerebral ischaemia or hypoperfusion, gasembolism, un­recognized haemorrhage, inadvertent blockage of ana­esthesia drug delivery) [9] .

In several case reports, it is suggested that routine intraoperative events (e.g., administration of depolariz­ing muscle relaxants, activation of electromagnetic equip­ment or devices, patient warming or planned hypother­mia) may interfere with BIS functioning and patients might be experiencing intraoperative awareness despite moni­tored values indicating an adequate depth of anaesthe­sia [9] . It is interesting to note that in patients with demen­tia, baseline BIS value ("awake") is found to be lower than normal subjects [21] .

BIS demonstrates a dose-response relationship with inhalational and hypnotic intravenous agents, such as propofol and midazolam, which is independent of the agent(s) being used and correlates with clinical assess­ments of the level of consciousness. Bispectral analysis is the first processed EEG technique to be correlated well with behavioural assessments of level of consciousness. Ketamine and sometime N 2 O however, cause EEG acti­vation, complicating BIS interpretation. Baseline BIS val­ues are not reduced by nitrous oxide, at inspired concentrations of up to 50%. Furthermore, the addition of nitrous oxide to established anaesthesia has little or no effect on BIS in the absence of surgical stimulation. However, dur­ing surgery, the anti-nociceptive effects of N 2 O may be responsible for the observed decrease in BIS.

BIS can be used as a continuous monitor of seda­tion in adult intensive care, and investigations have con­cluded that it is a useful reflector of the great inter-indi­vidual variations in pharmacokinetics and pharmacody­namics of sedatives in critically ill patients. Comparison of BIS values at various clinical end-points between adults and children suggest that BIS performs similarly in adults and children with respect to dose response to anaes­thetic agents, however, it is important to note that healthy adult EEG data were used to authenticate the BIS algo­rithm, it cannot automatically be extrapolated to young children, as the paediatric EEG only approaches the adult pattern by about 5 years of age. However, early investi­gations suggest that BIS may be valid in children older than 1 year of age and recently it is concluded by Sadhasivam S et al in their study that it is a quantitative, non-disruptive and easy to use depth of sedation monitor in children [22] . To conclude, results from the paediatric studies conducted to date demonstrate that the current BIS provides useful clinical information in children and infants, and shows promise for use in paediatric anaes­thesia practice in similar ways to its use in adults. It has been shown that BIS correlated with clinically assessed sedation levels and is useful for assessing sedation in paediatric intensive care unit and for differentiating ad­equate from inadequate sedation [23] . BIS has been proved to be useful during safe removal of LMA in children during awakening from anaesthesia and it is recom­mended that at BIS 60, LMA can be safely removed without much complication [24] .

BIS has also shown to have reduced consumption of anaesthetic agents which ultimately helps reducing overall cost of anaesthesia delivery system. Future use of BIS is quite promising especially during sleep studies, monitoring cerebral ischaemia, and use during sedation of patients in the ICU. It has been further found that significant correlation exists between Glasgow Coma Scale and BIS in patients with mild and moderate head injury, thus opening a vast era of research in this sub-set of patients [25] .

(vii) Entropy: Entropy monitoring is based on ac­quisition and processing of raw EEG and FEMG signals by using the Entropy algorithm. Entropy describes the irregularity, complexity, or unpredictability characteris­tics of a signal. It is a property of a physical system or data string consisting of a great number of elements. By adding the measurement of the cortical electrical activ­ity, the clinician can assess the effect of anaesthetics more comprehensively. EEG recordings change from irregular to more regular patterns when anaesthesia deepens. Entropy of the signal has been shown to drop when a patient falls asleep and increase again when the patient wakes up. Similarly, FEMG quiets down as the deeper parts of the brain are increasingly saturated with anaesthetics.

A single sine wave represents a completely pre­dictable signal (entropy = 0), whereas noise from a ran­dom number generator represents entropy = 1. The al­gorithm for calculation of entropy in the EEG signal as incorporated in the Datex-Ohmeda S/5 entropy Module (Datex-Ohmeda, Inc., Madison, WI) is in the public do­main, and detailed descriptions have recently been pub­lished [26] . Entropy is independent of absolute scales such as the amplitude or the frequency of the signal. The com­mercially available Datex-Ohmeda module calculates entropy over time windows of variable duration and re­ports two separate entropy values. State entropy (SE) is an index ranging from 0 to 91 (awake), computed over the frequency range from 0.8 to 32 Hz, reflecting the cortical state of the patient. Response entropy (RE) is an index ranging from 0 to 100 (awake), computed over a frequency range from 0.8 to 47 Hz, containing the higher EMG-dominated frequencies, and will thus also respond to the increased EMG activity resulting from inadequate analgesia. Noxious stimulation increases the difference between RE and SE, however, it is reported that an increase in the difference does not always indi­cate inadequate analgesia and should be interpreted care­fully during anaesthesia [27] . No clinical trials or other com­parative studies were found that examine the impact of entropy monitoring on the incidence of intraoperative awareness. In a recent study, Bonhomme V et al found that SE is globally well correlated with BIS [28] . Further, Vakkuri A et al have been reported that entropy moni­toring assists better titration of propofol, especially during the last part of the procedures, as indicated by higher entropy values, decreased consumption of propofol, and shorter recovery times in the entropy group [29] . Entropy also provides a reproducible hypnosis index for patients undergoing supratentorial neurosurgical procedures [30] .

(viii) Narcotrend®: The Narcotrend® (Monitor Technik, Bad Bramstedt, Germany) is an EEG monitor designed to measure the depth of anaesthesia and has been developed at the University Medical School of Hannover, Germany. The newest Narcotrend® software version includes a dimensionless Narcotrend index from 100 (awake) to 0 (electrical silence). The raw EEG sig­nal can be recorded by standard ECG electrodes for single-and double-channel registration. The Narcotrend® monitor provides a vast amount of infor­mation: the actual Narcotrend® stage and index, the trend ('cerebrogram'), the raw EEG signal and a power spec­trum and several derived EEG parameters. In brief, two commercially available electrodes are placed on the fore­head of the patient; a third electrode serves as a refer­ence [Figure 2]. After artifact analysis a multivariate sta­tistical algorithm transforms the raw EEG data finally resulting in a 6-letter classification of the depth of ana­esthesia. After artifact exclusion and Fourier transfor­mation, the original electronic algorithm classified the raw frontal EEG according to the following system: A (awake), B (sedated), C (light anaesthesia), D (general anaesthe­sia), E (general anaesthesia with deep hypnosis), F (gen­eral anaesthesia with increasing burst suppression). The system included a series of sub-classifications resulting in a total of 14 possible sub-stages: A, B0-2, C0-2, D0-2, E0-1, and F0-1 [31] .

In the most recent version (4.0) of the Narcotrend® software, the alphabet-based scale has been "translated" into a numerical scaling index system which called as the Narcotrend® index. This is scaled quantitatively simi­lar to BIS scale viz. 0 (deeply anaesthetized) to 100 (awake). No clinical trials or other comparative studies were found that examine the impact of Narcotrend® monitoring on the incidence of intraoperative awareness. Kreuer S et al in a recent study demonstrate that an increase of the hypnotic component of anaesthesia as indicated by BIS is accompanied by corresponding ef­fects as displayed by the Narcotrend® during propofol­remifentanil anaesthesia. The Narcotrend® stages D or E are assumed equivalent to BIS values between 64 and 40 in > 93% cases indicating general anaesthesia [32] .

One RCT has compared the use of Narcotrend®­ controlled versus clinically controlled anaesthetic admin­istration and found a shorter recovery time in the Narcotrend® group (i.e., opened eyes) after termina­tion of anaesthesia [33] . The reported mean Narcotrend® values are as follows: after induction (loss of response), 72-80; and at emergence or end of surgery (spontane­ously opened eyes), 80 [34] . In a recent study, however, Narcotrend® is found unable to differentiate reliably between conscious and unconscious patients during gen­eral anaesthesia when neuromuscular blocking agents are used [35] . Narcotrend® has also been used in children during propofol/remifentanil anaesthesia and sevoflurane anaesthesia. It is found to reduce propofol consumption compared to a conventional clinical practice and end-­tidal sevoflurane concentrations are more closely related with narcotrend index than with MAP or HR [36],[37] .

Patient state analyzer: The Patient State Index (PSI; Physiometrix, North Billerica, MA) [Figure 3] is derived from a four-channel EEG. The derivation of the PSI is based on the observation that there are re­versible spatial changes in power distribution of quanti­tative EEG at loss and return of consciousness. The PSI has a range of 0-100, with decreasing values indicating decreasing levels of consciousness or increasing levels of sedation, similar to BIS, entropy, and Narcotrend®. The PSI algorithm, calculated via a proprietary algorithm by a high-resolution 4-channel EEG monitor after advanced artifact rejection. The algorithm relies on EEG power, frequency and phase information from anterior-­posterior relationships of the brain as well as coherence between bilateral brain regions. It is constructed using stepwise, discriminant analysis based on multivariate combinations of quantitative EEG variables, derived af­ter Fourier transformation of the raw EEG signal, and found to be sensitive to changes in the level of anaesthe­sia. PSI is a clinically validated measure of the effect of anaesthesia and sedation and has been designed specifi­cally for intra-operative and intensive care use to moni­tor patient sedation and drug effect. The PSI monitor, initially called the PSA 4000, is also called the SED Line monitor, the newest generation of the device. The SED Line system provides the clinician the option of storing and downloading patient data for future use as well as monitoring bilateral brain function and symmetry with a density spectral array (DSA) display. No clinical trials or other comparative studies were found that examine the impact of PSI monitoring on the incidence of intra­operative awareness. One study reported a significant correlation of the PSI with unconsciousness [38] . Reported mean PSI values are as follows: before induction or baseline, 92; during surgery, 32;at emergence or end of surgery, 53;and during postoperative recovery, 81 [38] . PSI has also been used to quantify the level of propofol/ sufentanil sedation in ICU patients [39] .

(x) SNAP index: The SNAPII (Everest Biomedi­cal Instruments, Chesterfield, MO) [Figure 4] calculates a "SNAP index" from a single channel device intended to monitor a patient's EEG. It samples raw EEG signals and uses its own unique algorithm, analyses both high­(80-420 Hz) and low- (0-20 Hz) frequency components of the signal. This is termed the SNAP index, and it ranges from 100 (arbitrarily representing the fully awake state) to 0 to provide functional data points for patient man­agement. The SNAP is the first commercial EEG-moni­toring tool to use Personal Digital Assistant computer technology. The first version of SNAP index was intro­duced in 2002, and so far there has been little experi­ence with the SNAP device reported in the literature. Compared with other EEG devices, there is no evidence that SNAP is superior to others in generating more spe­cific information about 'depth of sedation'.

There are no published data on the actual algo­rithm used to calculate the SNAP index, which is based on a composite of both low-frequency (0-40 Hz) and high-frequency (80-420 Hz) components. No clinical trials or other comparative studies were found that ex­amine the impact of SNAP monitoring on the incidence of intraoperative awareness. One correlational study was found that reported a mean SNAP index of 71 to be predictive of a loss of consciousness in 95% of elective surgery patients [40] . Same author, in a recent study, how­ever, compares SNAP with BIS, and concluded that SNAP index tracks loss of consciousness and emergence from sevoflurane and sevoflurane/nitrous oxide anaes­thesia and there is significant bias exists between the SNAP and BIS indices and therefore, the indices are not interchangeable. They further observed that the SNAP index returns to baseline before awakening, whereas the BIS index remains below baseline at awak­ening, suggesting that the SNAP index may be more sensitive to unintentional awareness [41] .

(xi) Cerebral State Monitor/Cerebral State In­dex (CSI): The Cerebral State Monitor (Danmeter A/S, Odense, Denmark) [Figure 5] is a handheld device that ana­lyzes a single channel EEG and presents a CSI scaled from 0to 100.In addition, it also provides EEG suppression percentage and a measure of EMG activity (75-85 Hz). The EEG waveform is derived from the signal recorded be­tween the frontal and mastoid electrodes. The frequency content is 2-35 Hz. The performance of the CSI is based on the analysis of the frequency content of the EEG signal. The energy of the EEG is evaluated in specific frequency bands. These are used to define two energy ratios called alpha (α) and beta (β). Both of these show a shift in en­ergy content from the higher to the lower frequencies dur­ing anaesthesia. The relationship between these quantities is also analyzed as a separate parameter (β-α). The moni­tor also on-line evaluates the amount of instantaneous burst suppression (BS) in each thirty-second period of the EEG.The four parameters (αratio ratio ,β - α shift & BS) are used as input to a fuzzy logic classifier system that calculates the CSI [Figure 6]. The CSI is a unit-less scale from 0 to 100, where 0 indicates a flat EEG and 100 indicate EEG activity corresponding to the awake state. The range of adequate anaesthesia is designed to be between 40 and 60. All val­ues in the table are approximate values based on the mean values of the patient behaviour. The relationship between the CSI, the clinical state and the OAAS score [Table 2] is shown in the [Table 3].

High levels of facial muscular or EMG activity can interfere with the CSI under certain circumstances. The monitor incorporates an EMG filter that removes most of the potential interfering EMG activity. The EMG bar (shown in monitor) shows the energy of the EMG level in the 75-85 Hz frequency band (0-100 logarithmic). EMG activity is expected to be present when the patient is awake. When the patient is asleep, EMG activity can increase due to (i) reflex reactions to painful stimuli dur­ing surgery, (ii) lack of muscular relaxation, (iii) muscu­lar rigidity caused by some opioids (analgesics) and, (iv) presence of large external electrical fields, e.g. diathermy. The monitor also shows a BS% indicator to show peri­ods when the EEG is iso-electric during 20% of the last 30 seconds. It analyses the frequency shifts that take place in the EEG signal as the level of consciousness changes. Based on this principle, the monitor calculates the CSI, which is used to estimate the level of conscious­ness of the patient. No published literature was found that examined the impact of using the Cerebral State Monitor on the incidence of intraoperative awareness. However, Anderson RE et al reported that CSI corre­lated well with BIS and show similar patterns and nu­merical values in day-surgery anaesthesia without muscle relaxation, however, which monitor is the more depend­able remains to be established in such subset of patients [42] . In a recent study, it has been further found that the CSI detects well the graduated levels of propofol anaesthe­sia when compared with the propofol effect site con­centration and the OAAS score [43] and it behaves as other depth of anaesthesia monitors with a progressive de­crease during propofol induction but loss of conscious­ness with N 2 O results no change in CSI [44] .

2. Evoked brain electrical activity monitors: Evoked potential monitors measure electrical activity in certain areas of the brain in response to stimulation of specific sensory nerve pathways.

(i) Somatosensory evoked potentials (SSEP): A supramaximal stimulus is applied to peripheral nerves while a recording scalp electrode is placed over the ap­propriate sensory area. In general, most anaesthetic agents increase the latency and decrease the amplitude in a dose-dependent manner. Etomidate consistently in­ creases the amplitude.

(ii) Visual evoked potentials (VEP): Light-emit­ting diodes are incorporated into specialized goggles and the optic nerve is stimulated at 2 Hz. EEG electrodes take recordings from the occiput. Mostanaesthetic agents increase the latency and decrease the amplitude of P100 in a dose-dependent manner. Although VEP are con­sidered less reliable than AEP, they have been used to monitor function during surgery for lesions involving the pituitary gland, optic nerve and chiasma.

(iii) Auditory evoked potential (AEP): The AEP is defined as the passage of electrical activity from the cochlea to the cortex, which produces a waveform con­sisting of 15 waves. The waveform can be divided into three parts: Brainstem Auditory Evoked Potential (BAEP), Middle Latency Auditory Evoked Potential (MLAEP) and Long Latency Auditory Evoked Poten­tial (LLAEP). These parts indicate the sites in the brain from which the various waves are thought to originate [Figure 7]. The BAEP is represented by the Roman nu­merals I - VI and extends from 0 to 10 ms after the stimulus. These waves represent the process of stimu­lus transduction in the brainstem: acoustic nerve (I), co­chleae nucleus (II), superior olivary complex (III), ven­tral nucleus of the lateral leminiscus and preolivary re­gion (IV), inferior colliculus (V), and medial geniculate body (VI). The early cortical or MLAEPs, marked by the waves N0, P0, Na, Pa and Nb, are thought to origi­nate from the medial geniculate body and the primary auditory cortex. These waves occur from 10 to 100 ms after the stimulus. The third part, more than 100 ms af­ter the stimulus, is called a LLAEP and consists of waves P1, N1, P2 and N2. It reflects the neural activity of the frontal cortex and association areas. The AEP window of this monitor shows the BAEP and MLAEP. The BAEP is presented as a smoothed curve; therefore, typi­cally only wave V can be detected. In the MLAEP, typi­cally Na, Pa and Nb can be observed. The AEP tech­nology actively measures the brain's reaction to acous­tic stimuli. It's the natural choice for measuring patient consciousness under anaesthetic because hearing is the last retained sense during anaesthesia and the first to be regained prior to waking. Re-usable headphones/ear phones deliver the active stimulation, cost-effective dis­posable surface electrodes are used to measure the AEP. The result is fast information to enable you to accurately measure the patient's level of consciousness.

The effects of anaesthetics on AEP have been stud­ied since the early 1980s [45] . The brainstem response is relatively insensitive to anaesthetics, whereas early cor­tical responses (MLAEPs), change predictably with in­creasing concentrations of both volatile and intravenous anaesthetics. The typical AEP response to increasing anaesthetic concentrations is increased latency and de­creased amplitude of the various waveform components. These signals are extremely small (<1µV), necessitating extraction from the spontaneous EEG using signal aver­aging techniques. Before recent innovations, signal av­eraging was relatively time consuming (several minutes per averaged waveform). More recent signal filtering advances have resulted in an instrument (A-Line®; Danmeter) that can record and rapidly update a single channel of AEPs from forehead electrodes [Figure 8]. From a mathematical analysis of the AEP waveform, the de­vice generates an "AEP index" that provides a correlate of anaesthetic concentration. This index ranged from 0- 100, however, an AAI 0-60 range is available as well. When using the 0-60 range, fewer oscillations are ob­served while the patient is awake and the graphical reso­lution of the lower index values while asleep is higher. It is recommended to use the AAI 0-60 range. The AAI index is calculated in the 20-80 ms window of the AEP and latency and amplitude changes in the AEP are weighted equally. As BAEP and LLAEP do not correlate well to the level of consciousness, the window length is chosen to include only the middle latency AEP. The AAI is defined to reflect the hypnotic level during ana­esthesia/sedation. The AAI is a linear combination of contributions from the AEP and EEG . If the SNR is ad­equate, the main weight is on the AEP but, if the SNR decreases, the weight on the EEG is increased in a gradual manner. When burst suppression is present, this component is included in the AAI as well. The recommended AAI values for surgical anaesthesia are 15-25 [Figure 9]. In contrast to many EEG indices, the AAI cor­responding with low probability of consciousness is less than 25, rather than the higher numeric thresholds asso­ciated with the other monitors. The monitor takes ad­vantage of the additional information provided by the spontaneous EEG activity. During loss of consciousness, the energy of the EEG frequency spectrum shifts from predominantly higher (α, & β activity) to lower frequen­cies (δ band). This energy shift is quantified by a propri­etary algorithm analyzing frequencies in the 3-47 Hz band. This information is included in the calculation of the AAI when the Signal to Noise Ratio (SNR) of the AEP is low. Very deep anaesthesia can also cause near­ suppression of the AEP. In this case, spontaneous EEG enhances the AAI performance by increased resolution during this phase.

RCT that compared MLAEP monitoring (e.g., to titrate anaesthetics) to standard clinical practice without MLAEPs reported reduced times to eye opening or ori­entation[46] . Descriptive studies reported ranges of mean values as follows: before induction or baseline, 73.5- 85; at or after induction, 33.4-61; during surgery, 21.1- 37.8; at emergence or end of surgery, 24.6-40; and dur­ing postoperative recovery, 89.7[47],[48] [Figure 9]. Alpiger S et al in their two different studies showed that AAI indi­cates the depth of anaesthesia necessary for acceptable 7endotracheal intubation/laryngeal mask insertion condi­tions; however, end-expiratory sevoflurane concentration is found to be a better predictor and may turn out to be more useful in the clinical setting[49],[50] . Nishiyama T investigated sensitiveness about arousal detector of AAI monitor during propofol-fentanyl-nitrousoxide anaesthe­sia and found that the AAI responded to LMA insertion or surgical incision, but not the BIS, and the AAI had smaller variations[51] . Further, the AAI recovered faster from the disturbance by electrocautery than the BIS and concluded that the AAI may be a more sensitive and useful detector of arousal than the BIS[51] .

AEP index and children -
Anaesthesia manage­ment in children is determined by their special psycho­logical and physiological characteristics. The assessment of anaesthetic depth can be difficult. In children, this situation becomes more evident, especially when at­tempting to use classic scales based on the response to verbal commands, which is often unreliable. In this sense, the paediatric anaesthesiologists can benefit from the added information provided by the AEP Monitor/2. It can be safely used on children over 2 years of age with minimal adjustments to the settings. The AAI reference values are the same for adults. For children under 10 years it is advisable to place the negative (black) elec­trode on the left cheekbone for improved performance.

Anaesthesia to prevent awareness and approach­ing the aware patient:

Since there is no readily available definition of 'un­consciousness' or a practical monitor to measure it, the proper anaesthetic technique to prevent awareness rests on careful clinical monitoring of the patient. In addition to regular checking of the apparatus and detailed record­keeping (all of which should be good anaesthetic prac­tice), the following approach may also help to prevent awareness:

  1. Unpremedicated patients may need larger doses of intravenous induction agent.
  2. The level of inhalational anaesthetic agent during sur­gery should be monitored (i.e. end-tidal gas monitor­ing), recorded and maintained at a level known from published data, sufficient to keep the patient asleep.
  3. The level of analgesia should be sufficient to en­sure that if the patient is aware, s/he is not in pain. If it is suspected awareness might be a possibility, consideration should be given to the use of an am­nesic drug (e.g. midazolam) so that if the patient is aware and in pain, s/he will not recall the event. The patient is thus spared the ill-effects of possible post-traumatic stress disorder.
  4. It may be prudent to use earplugs or headphones transmitting music or white noise: should the patient be only semiconscious, s/he may not associate any sensations with an operation.

If a patient does declare after an operation that s/ he has been aware, then the following course of action is sensible:

  1. The anaesthesiologists who conducted the anaes­thetic should be informed and personally visit the patient.
  2. The anaesthesiologists should check the anaesthetic record and, if possible, re-check any equipment which was used for faults.
  3. The anaesthesiologists should also acknowledge that's/he believes the patient's account of events, apologize, and reassure the patient explaining how the awareness might have occurred.
  4. A note should be made in the medical records so that future anaesthesiologists are aware of the prob­lem. A full account of the interview with the patient should also be made.
  5. Junior anaesthesiologists should inform their con­sultant, who should be present and/or also visit the patient.
  6. Psychological counselling may need to be arranged for the patient.
The post-operative visit may be difficult if the pa­tient is unhappy as a result of their experience, but a sympathetic approach must be taken and make it clear that, they believe the patient. In general terms, aware­ness despite correct procedure and meticulous record­keeping may be excusable; awareness with pain or awareness due to faulty anaesthetic technique is ex­tremely difficult to defend. In some cases (e.g. the seri­ously ill) it may be advisable to warn patients before the operation that low doses of anaesthetic are to be used for reasons of safety, but to reassure them that they will always be pain-free. Patients usually accept this expla­nation: one example comes from neurosurgical patients who are sometimes woken up with their consent during surgery and asked to perform motor tasks to ensure that vital parts of the brain are intact. The checklist would be useful for the purpose [Table 4]

[TAG:2]ASA Task force recommendation about monitor­ing depth of anaesthesia[9][/TAG:2]

  1. Intraoperative monitoring of depth of anaesthesia, for the purpose of minimizing the occurrence of awareness, should rely on multiple modalities, in­cluding clinical techniques (e.g., checking for clini­cal signs such as purposeful or reflex movement) and conventional monitoring systems (e.g., electro­cardiogram, blood pressure, HR, end-tidal anaes­thetic analyzer, capnography). The use of neuro­muscular blocking drugs may mask purposeful or reflex movements and adds additional importance to the use of monitoring methods that assure the adequate delivery of anaesthesia.
  2. Brain electrical activity monitor is valuable in moni­toring depth of anaesthesia but should not be used to assess intraoperative depth of anaesthesia for all patients. It should be used to assess intraopera­tive depth of anaesthesia for selected patients that may place the mat risk and patients requiring smaller doses of general anaesthetics.
  3. Brain function monitoring is not routinely indicated for patients undergoing general anaesthesia, either to reduce the frequency of intraoperative aware­ness or to monitor depth of anaesthesia. Use of a brain function monitor should be made on a case-­by-case basis by the individual practitioner for se­lected patients that may place them at risk and pa­tients requiring smaller doses of general anaesthetics, trauma surgery, caesarean delivery, and total intra­venous anaesthesia.

   Conclusion Top

Monitoring depth of anaesthesia is a newer advance in the monitoring of anaesthesia. Its increasing use may help prevent awareness of anaesthesia which is not un­common because of development of short acting anaesthetics and increase in number of high risk patients subjected for different surgery where anaesthesia is tai­lored to avoid haemodynamic disturbances. However, prevention of awareness not only involves sophisticated monitoring but also involves fine clinical judgment, the checking of all equipment, ensuring the uninterrupted delivery of anaesthetic to patients via intact circuits and intravenous access and the use of familiar, appropriate techniques by competent practitioners. Also, reassuring those patients, who had awareness despite best use of anaesthetics & monitoring devices, that they can safely have further general anaesthetics, with minimal risk of a further episode of awareness and offering psychologi­cal support, apart from documenting that this has been offered remain a cornerstone in the quality management of anaesthesia.

   References Top

1.Sandin RH, Enlund G, Samuelsson P, Lennmarken C. Aware­ness during anaesthesia: A prospective case study. Lancet 2000; 355: 707-11.  Back to cited text no. 1      
2.Sebel PS, Bowdle TA, Ghoneim MM, et al. The incidence of awareness during anaesthesia: A multicenter United States study. Anesth Analg 2004; 99: 833-39.  Back to cited text no. 2      
3.Domino KB, Posner KL, Caplan RA, Cheney FW. Awareness during anesthesia - A closed claim analysis. Anesthesiology 1999; 90: 1053-61.  Back to cited text no. 3      
4.Lennmarken C, Bildfors K, Enlund G, SamuelssonP, Sandin R. Victims of awareness. ActaAnaesthesiol Scand 2002; 46:229-31.  Back to cited text no. 4      
5.Griffith D, Jones JB. Awareness and memory in anaesthetised patients. Br J Anaesth 1990; 65: 603-7.  Back to cited text no. 5      
6.Hargrove RL. Awareness under anaesthesia. J Medical Defence Union 1987; (Spring): 9-11.  Back to cited text no. 6      
7.Stoelting RK, Longnecker DE, Eger El 2nd. Minimum alveolar concentrations in man on awakening from methoxyflurane, ha­lothane, ether and fluroxene anesthesia: MAC awake. Anesthe­siology 1970; 33: 5-9.  Back to cited text no. 7      
8.Evans JM, Davies WL. Monitoring anaesthesia. Clin Anesth 1984; 2: 243-62.  Back to cited text no. 8      
9.Anonymous. Practice advisory for intraoperative awareness and brain function monitoring, AReport by theAmerican Soci­ety of Anesthesiologists Task Force on Intraoperative Aware­ness. Anesthesiology 2006; 104: 847-64.  Back to cited text no. 9      
10.Goddard GF. Apilot study of changes in skin electrical conduc­tance in patients undergoing general anaesthesia and surgery. Anaesthesia 1982; 37: 408-15.  Back to cited text no. 10      
11.Herregots L, Rolly G, Mortier E, Bogaert M, Mergaert C. EEG and SEMG monitoring during induction and maintenance of anaesthesia with propofol. Int J Clin Monit Comput 1989; 6: 67-73.  Back to cited text no. 11      
12.Evan JM, Davies WL, Wise CC. Lower oesophageal contrac­tility: A new monitor of anaesthesia. Lancet 1984; 1: 1157.  Back to cited text no. 12      
13.Isaac PA, Rosen M. Lower oesophageal contractility and de­tection of awareness during anaesthesia. Br J Anaesth 1990; 65: 319-24.  Back to cited text no. 13      
14.Healy TEJ, Bellman MH, Pomfrett CJD. Respiratory sinus arrhythmia indicates light anaesthesia during caesarean section. Anesth Analg 1994; 78: S156.  Back to cited text no. 14      
15.Pomfrett LJD, Barric JR, Healy TEJ. Respiratory sinus ar­rhythmia reflects surgical stimulation during light enflurane anaesthesia. Anesth Analg 1994; 78: S 334.  Back to cited text no. 15      
16.Rosow C, Manberg PJ. Bispectral index monitoring. Anesth Clin N Am 2001; 19: 947-66.  Back to cited text no. 16      
17.Glass PS, Bloom M, Kearse L, Rosow C, Sebel P, Manberg P. Bispectral analysis measures sedation and memory effects of propofol, midazolam, isoflurane, and alfentanil in healthy vol­unteers. Anesthesiology 1997; 86: 836-47.  Back to cited text no. 17      
18.Myles PS, Leslie K, McNeil J, Forbes A, Chan MTV. Bispectral index monitoring to prevent awareness during ana­esthesia: The B-aware randomized controlled trial. Lancet 2004; 363: 1757-63.  Back to cited text no. 18      
19.Puri GD, Murthy SS. Bispectral index monitoring in patients undergoing cardiac surgery under cardiopulmonary bypass. Eur J Anaesth 2003; 20: 451-6.  Back to cited text no. 19      
20.Burrow B, McKenzie B, Case C. Do anaesthetized patients recover better after bispectral index monitoring? Anaesth Intensive Care 2001; 29: 239-45.  Back to cited text no. 20      
21.Renna M, Handy J, Shah A. Low baseline Bispectral Index of the electroencephalogram in patients with dementia. Anesth Analg 2003; 96: 1380-85.  Back to cited text no. 21      
22.Sadhasivam S, Ganesh A, Robison A, et al. Validation of the bispectral index monitor for measuring the depth of sedation in children. Anesth Analg 2006; 102: 383-88.  Back to cited text no. 22      
23.Berkenbosch JW, Fichter CR, Tobias JD. The correlation of the bispectral index monitor with clinical sedation scores dur­ing mechanical ventilation in the pediatric intensive care unit. Anesth Analg 2002; 94: 506-11.  Back to cited text no. 23      
24.Sinha A, Sood J. Safe removal of LMA in children - at what BIS? Paediatr Anaesth 2006; 16:1144-47.  Back to cited text no. 24      
25.Paul DB, Umamaheswara Rao GS. Correlation of Bispectral Index with Glasgow Coma Score in mild and moderate head injuries. J Clin Monit Comput 2006; 20: 399-404.  Back to cited text no. 25      
26.Viertio-Oja H, Maja V, Sarkela M, et al. Description of the entropy algorithm as applied in the Datex-Ohmeda S/5 En­tropy Module. Acta Anaesth Scand 2004; 48: 154-61.  Back to cited text no. 26      
27.Takamatsu I, Ozaki M, Kazama T. Entropy indices vs the bispectral index for estimating nociception during sevoflurane anaesthesia. Br J Anaesth 2006; 96: 620-26.  Back to cited text no. 27      
28.Bonhomme V, Deflandre E, Hans P. Correlation and agreement between bispectral index and state entropy of the electroen­cephalogram during propofol anaesthesia.Br J Anaesth 2006; 97:340-46.  Back to cited text no. 28      
29.Vakkuri A, Yli-Hankala A, Sandin R, et al. Spectral entropy monitoring is associated with reduced propofol use and faster emergence in propofol-nitrous oxide-alfentanil anesthesia. An­esthesiology 2005; 103: 274-79.  Back to cited text no. 29      
30.Paolo Martorano P, Falzetti G, Pelaia PJ. Bispectral index and spectral entropy in neuroanesthesia. J Neurosurg Anesthesiol 2006; 18: 205-10.  Back to cited text no. 30      
31.Schultz B, Schultz A, Grouven U. Sleeping stage based sys­tems (Narcotrend), In, New Aspects of High Technology in Medicine 2000. Eds. Bruch HP, Kockerling F, Bouchard R, Schug-Pab C. Bolognia, Monduzzi Editore, pp. 285-91.  Back to cited text no. 31      
32.Kreuer S, Biedler A, Larsen R, et al. The Narcotrend™ M - a new EEG monitor designed to measure the depth of anaesthesia. A comparison with bispectral index monitoring during propofol-­remifentanil-anaesthesia. Anaesthesist 2001; 50: 921-25.  Back to cited text no. 32      
33.Kreuer S, Biedler A, Larsen R, Altmann S, Wilhelm W. Narcotrend monitoring allows faster emergence and a reduction of drug consumption in propofol-remifentanil anaesthesia. Anesthesiology 2003; 99: 34-41.  Back to cited text no. 33      
34.Kreuer S, BruhnJ, Larsen R, Bialas P, Wilhelm W. Comparabil­ity of Narcotrend index and bispectral index during propofol anaesthesia. Br J Anaesth 2004; 93: 235-40.  Back to cited text no. 34      
35.Russell IF. The Narcotrend 'depth of anaesthesia' monitor can­not reliably detect consciousness during general anaesthesia: an investigation using the isolated forearm technique. Br J Anaesth 2006; 96: 346-52.  Back to cited text no. 35      
36.Weber F, Pohl F, Hollnberger H, Taeger K. Impact of the Narcotrend Index on propofol consumption and emergence times during total intravenous anaesthesia with propofol and remifentanil in children: a clinical utility study. Eur JAnaesthesiol 2005; 22:741-47.  Back to cited text no. 36      
37.Weber F, Hollnberger H, Gruber M, et al. The correlation of the Narcotrend Index with endtidal sevoflurane concentrations and hemodynamic parameters in children. Paediatr Anaesth 2005; 15:727-32.  Back to cited text no. 37      
38.Chen X, Tang J, White PF, et al. A comparison of patient state index and bispectral index values during the perioperative pe­riod. Anesth Analg 2002; 95: 1669-74.  Back to cited text no. 38      
39.Schneider G, Heglmeier S, Schneider J, et al. Patient State Index(PSI) measures depth of sedation in intensive care pa­tients. Intensive Care Med 2004; 30: 213-16.  Back to cited text no. 39      
40.Wong CA, Fragen RJ, Fitzgerald PC, McCarthy RJ. The asso­ciation between propofol-induced loss of consciousness and the SNAP TM index. Anesth Analg 2005; 100: 141-48.  Back to cited text no. 40      
41.Wong CA, Fragen RJ, Fitzgerald P, McCarthy RJ. A compari­son of the SNAP II and BIS XP indices during sevoflurane and nitrous oxide anaesthesia at 1 and 1.5 MAC and at awakening. Br J Anaesth 2006;97:181-86.  Back to cited text no. 41      
42.Anderson RE, Jakobsson JG. Cerebral state monitor, a new small handheld EEG monitor for determining depth of anaes­thesia: a clinical comparison with the bispectral index during day-surgery. Eur J Anaesthesiol 2006; 23: 208-12.  Back to cited text no. 42      
43.Jensen EW, Litvan H, Revuelta M, et al. Cerebral state index during propofol anesthesia: a comparison with the bispectral index and the A-line ARX index. Anesthesiology 2006; 105: 28-33.  Back to cited text no. 43      
44.Anderson RE, Barr G, Jakobsson JG. Cerebral state index dur­ing anaesthetic induction: a comparative study with propofol or nitrous oxide. Acta Anaesthesiol Scand 2005; 49: 750-53.  Back to cited text no. 44      
45.Schwender D, Conzen P, Klasing S, et al. The effects of anaes­thesia with increasing end-expiratory concentrations of sevoflurane on mid-latency auditory evoked potentials. Anesth Analg 1995; 81: 817-22.  Back to cited text no. 45      
46.Recart A, Gasanova I, White PF, et al. The effect of cerebral monitoring on recovery after general anaesthesia: A compari­son of the auditory evoked potential and bispectral index de­vices with standard clinical practice. Anesth Analg 2003; 97: 1667-74.  Back to cited text no. 46      
47.Kreuer S, Bruhn J, Larsen R, Hoepstein M, Wilhelm W. Com­parison of AlarisAEP index and bispectral index during propofol­-remifentanil anaesthesia. Br J Anaesth 2003; 91: 336-40.  Back to cited text no. 47      
48.Anderson RE, Barr G, Assareh H, Jakobsson J. The AAI index, the BIS index and end-tidal concentration during wash in and wash out of sevoflurane. Anaesthesia 2003; 58: 531-35.  Back to cited text no. 48      
49.Alpiger S, Helbo-Hansen HS, Vach W, Ording H. Efficacy of A-line AEP Monitor as a tool for predicting acceptable tracheal intubation conditions during sevoflurane anaesthesia. Br J Anaesth 2005; 94: 601-606.  Back to cited text no. 49      
50.Alpiger S, Helbo-Hansen HS, Vach W, Ording H. Efficacy of the A-line AEP monitor as a tool for predicting successful in­sertion of a laryngeal mask during sevoflurane anesthesia. Acta Anaesthesiol Scand 2004; 48: 888-93.  Back to cited text no. 50      
51.Nishiyama T, Hanaoka K. The A-line ARX index may be a more sensitive detector of arousal than the bispectral index during propofol-fentanyl-nitrous oxide anesthesia: a prelimi­nary investigation. Can J Anaesth 2004; 51: 539-44.  Back to cited text no. 51      


  [Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6], [Figure 7], [Figure 8], [Figure 9]

  [Table 1], [Table 2], [Table 3], [Table 4]


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  In this article
    Methods of monit...
    ASA Task force r...
    Article Figures
    Article Tables

 Article Access Statistics
    PDF Downloaded5770    
    Comments [Add]    

Recommend this journal